Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01656707 · ClinicalTrials.gov registry record · NA
Adaptive Treatment for Adolescent Cannabis Use Disorders
A NA study of Cannabis Use Disorder and Mental Disorders, sponsored by UConn Health.
- Completed
- Registry status
- NA
- Development phase
- 172
- Enrollment target
- 1
- Study location
NCT01656707: Completed NA study of Cannabis Use Disorder and Mental Disorders, sponsored by UConn Health.
NCT01656707 is a NA study of Cannabis Use Disorder and Mental Disorders that has completed, run by UConn Health. The registered enrollment target is 172 participants, above the 104-participant average among 34 other Cannabis Use Disorder trials with a reported enrollment target (65% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01656707, a NA study of Cannabis Use Disorder and Mental Disorders, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 172 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine an Adaptive Treatment approach in order to improve outcomes of youth with Cannabis Use Disorders who are poor responders to treatment.
Primary Outcome
Each participant will serve as his/her own control. The outcomes will include the T-ASI, T-ASI-P, and drug urinalyses.
Conditions Studied
Interventions
- BEHAVIORAL CBT
- BEHAVIORAL ACRA
Study Locations (1)
Connecticut
- University of Connecticut Health Center - Farmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2011-09 |
| Est. Completion | 2016-07 |
| Phase | NA |
What the finished NCT01656707 record still lists
NCT01656707 is an interventional study that assigns participants to a tested intervention. The registered 172 participants enrollment target is mid-sized for trials with a published cap, above the 104-participant average among 34 other Cannabis Use Disorder trials with a reported enrollment target (65% higher).
The record links to 3 conditions, with Cannabis Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which CBT is the first listed.
NCT01656707 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT01656707 about?
NCT01656707 is a clinical study titled "Adaptive Treatment for Adolescent Cannabis Use Disorders". The purpose of this study is to examine an Adaptive Treatment approach in order to improve outcomes of youth with Cannabis Use Disorders who are poor responders to treatment.
What is the current status of trial NCT01656707?
This trial is currently completed. It is a NA study. The enrollment target is 172 participants. The study started on 2011-09. Estimated completion is 2016-07.
What conditions does trial NCT01656707 study?
This clinical trial studies the following conditions: Cannabis Use Disorder, Mental Disorders, Addictive Behaviors.
What interventions are being tested in trial NCT01656707?
The interventions under investigation include: CBT (BEHAVIORAL), ACRA (BEHAVIORAL).
Who is sponsoring clinical trial NCT01656707?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01656707 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cannabis Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01656707's enrollment target sits among peer trials
172 10th of 34 higher than 25 of 34 other Cannabis Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cannabis Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
RECRUITING · NA
-
Evaluation of a Brief Computerized and Smart Phone-based Intervention for Stress in Regular Cannabis Users
RECRUITING · NA
-
Determining the Effect of Six Weeks of Cannabis Abstinence on Fronto- Striatal fMRI Markers in Adolescents With Cannabis Use Disorder (ABSCAN)
RECRUITING · NA
-
The Neural Underpinnings of Depression and Cannabis Use in Young People Living With HIV
RECRUITING · NA
-
A Brief Intervention for Cannabis Use
RECRUITING · NA
-
Preliminary Efficacy Trial of a Digital Intervention for Depression and Cannabis Use
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04801797 · 172 participants · Phase 2
Venetoclax + Azacitidine vs. Induction Chemotherapy in AML
- NCT04867317 · 172 participants · Phase 3
Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
- NCT05357040 · 172 participants · Phase 2
Antidepressant Effects of Nitrous Oxide
- NCT05587517 · 172 participants · Phase 2
A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia